Prognostic value of CYFRA 21.1 in malignant mesothelioma: A brief report of the randomized phase II trial NVALT19

Author(s):: Gooijer, C.J. de; Noort, V. van der; Broek, D. van den; Baas, P. (0000-0001-7018-9556); Burgers, J.A.

Published: 2021
Publication type: Article / Letter to editor

Date issued: 2021-11-01
Language: English
Publisher: ELSEVIER IRELAND LTD
Is part of
hdl: 1887/3276388
doi: 10.1016/j.lungcan.2021.09.018